Stock listing

NASDAQ:SESN Sesen Bio Inc Stock

Follow Sesen Bio Inc into a list and get an email when it puts out news.

Delisted NASDAQ:SESN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SESN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Sesen Bio Inc on 6ix

Decks
34 decks · latest Apr 10, 2024

Decks

DeckKindSlidesDate
Carisma Therapeutics — Technical Presentation (April 2024)Technical9 slidesApr 10, 2024
Carisma Therapeutics — CAR-TCR Summit 2023Conference20 slidesSep 1, 2023
Merger or Acquisition (February 2023)Merger or acquisition17 slidesFeb 2, 2023
Merger or Acquisition (December 2022)Merger or acquisition24 slidesDec 12, 2022
Merger or Acquisition (September 2022)Merger or acquisition26 slidesSep 27, 2022
Technical Presentation (September 2021)Technical17 slidesSep 10, 2021
Jefferies Virtual Healthcare Conference 2021Conference74 slidesJun 4, 2021
Q1 2021 Earnings PresentationEarnings76 slidesMay 10, 2021
Corporate Update (March 2021)Corporate update84 slidesMar 15, 2021
Investor Presentation (March 2021)Investor deck82 slidesMar 1, 2021
All 34 decks
DeckKindSlidesDate
Corporate Update (January 2021)Corporate update82 slidesJan 11, 2021
Q3 2020 Earnings PresentationEarnings84 slidesNov 9, 2020
Corporate Update (October 2020)Corporate update77 slidesOct 13, 2020
H.C. Wainwright 22nd Annual Global Investment Conference (September 2020)Conference74 slidesSep 15, 2020
2020 Canaccord Genuity Global Growth ConferenceConference77 slidesAug 5, 2020
Corporate Update (July 2020)Corporate update77 slidesJul 31, 2020
2020 Jefferies Healthcare ConferenceConference69 slidesJun 2, 2020
Corporate Update (May 2020)Corporate update68 slidesMay 11, 2020
Corporate Update (March 2020)Corporate update62 slidesMar 16, 2020
J.P. Morgan 38th Annual Healthcare Conference 2020Conference67 slidesJan 10, 2020
Corporate Update (December 2019)Corporate update68 slidesDec 16, 2019
Q3 2019 Earnings PresentationEarnings66 slidesNov 8, 2019
H.C. Wainwright 21st Annual Global Investment Conference (September 2019)Conference62 slidesSep 10, 2019
2019 Canaccord Genuity Global Growth ConferenceConference53 slidesAug 7, 2019
Corporate Update (June 2019)Corporate update47 slidesJun 10, 2019
Q1 2019 Earnings PresentationEarnings45 slidesMay 13, 2019
Corporate Update (March 2019)Corporate update36 slidesMar 4, 2019
Corporate Update (January 2019)Corporate update24 slidesJan 4, 2019
Technical Presentation (January 2019)Technical22 slidesJan 3, 2019
American Urological Association 2018 Annual MeetingConference14 slidesMay 21, 2018
Eleven Biotherapeutics — Investor Presentation (October 2017)Investor deck39 slidesOct 20, 2017
Eleven Biotherapeutics — IPO Roadshow (October 2017)IPO roadshow39 slidesOct 20, 2017
Eleven Biotherapeutics — Investor Presentation (May 2017)Investor deck34 slidesMay 1, 2017
Eleven Biotherapeutics — Investor Presentation (January 2017)Investor deck42 slidesJan 6, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard F Fitzgerald
Other companies: 22nd Century Group, Inc (Chief Financial Officer · Nov 15, 2021 – Mar 21, 2022 · Past); Nauticus Robotics, Inc. (Chief Financial Officer · Jul 14, 2021 – Jul 14, 2021 · Past); Immunome, Inc. (Chief Financial Officer · Oct 1, 2020 – Oct 1, 2020 · Past); Eleven Biotherapeutics Inc (Chief Financial Officer · Oct 20, 2017 – Apr 9, 2018 · Past); PAVmed Inc. (CFO and Secretary · Jan 29, 2016 – Jun 1, 2016 · Past); TechPrecision Corporation (Chief Financial Officer · Jun 13, 2013 – Aug 12, 2015 · Past)
Chief Financial Officer · Feb 21, 2019 – Feb 21, 2019 · Past
Jason Keyes
Other companies: BlossomHill Therapeutics, Inc. (Executive Vice President and Chief Financial Officer · Since at least Aug 6, 2026); Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Equillium, Inc. (Chief Financial Officer · Dec 10, 2020 – Feb 14, 2025 · Past)
Director · May 3, 2021 – Jun 22, 2022 · Past
Peter Honig
Other companies: Karyopharm Therapeutics Inc. (Director · Dec 3, 2021 – May 24, 2023 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – Jun 4, 2015 · Past); Orexigen Therapeutics Inc (Director · Jun 5, 2013 – Jul 14, 2017 · Past)
Director · Jul 20, 2021 – Jun 22, 2022 · Past
Stephen A Hurly
Other companies: LAVA Therapeutics NV (Chief Executive Officer, Director · Since at least Jan 1, 2025); Eleven Biotherapeutics Inc (President and CEO, Director · Sep 20, 2016 – Apr 9, 2018 · Past)
President and CEO, Director · Jun 12, 2018 – Jun 12, 2018 · Past
Abbie Celniker
Other companies: Eleven Biotherapeutics Inc (Director · Jun 15, 2016 – May 19, 2017 · Past)
Director · Jun 12, 2018 – Jun 12, 2018 · Past
Mark Sullivan
Other companies: Definium Therapeutics, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Apr 13, 2023)
General Counsel & Secretary · Aug 1, 2019 – Mar 2, 2023 · Past
Glen C MacDonaldChief Technology Officer · Feb 19, 2021 – Mar 2, 2023 · Past
Kirstin AndersonPrincipal Accounting Officer · Aug 26, 2019 – Feb 19, 2021 · Past
Leslie DanDirector · Jun 12, 2018 – Jun 19, 2019 · Past
Thomas R CannellPresident and CEO, Director · Feb 13, 2020 – Mar 2, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Sesen Bio Inc.